Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development

Drug Discovery & Development

Bicycle, AstraZeneca enter into potential $1bn multitarget collaboration By PBR Staff Writer
Bicycle Therapeutics and AstraZeneca have agreed a $1bn multi-target collaboration across respiratory, cardiovascular and metabolic diseases.
Drug Research > Drug Discovery & Development > News
Evotec, Merck sign deals to partner on target discovery technologies Evotec and Merck have signed agreements to collaborate on target discovery technologies.
Drug Research > Drug Discovery & Development > News OxThera raises EUR32m to complete Oxabact development to treat primary hyperoxaluria Swedish privately-held biopharmaceutical firm OxThera has raised EUR32m to complete development of Oxabact for the treatment of primary hyperoxaluria.
Drug Research > Drug Discovery & Development > News
See more Drug Discovery & Development news

Latest Drug Discovery & Development News and Insight

View all Drug Discovery & Development news or find news targeted to your interests
Ergomed acquires PharmInvent
Pharmaceutical services and drug development firm Ergomed has acquired European PharmInvent Services s.r.o. (PharmInvent), a European pharmacovigilance and regulatory services business.
Drug Research > Drug Discovery & Development > News
UK biopharmaceutical firm Kymab secures $100m of funding
By PBR Staff Writer
UK-based biopharmaceutical firm Kymab has secured $100m of funding to advance its pipeline of therapeutic human monoclonal antibodies.
Drug Research > Drug Discovery & Development > News
WuXi Biologics, Prima sign non-binding MOU for biologics development
WuXi Biologics, a WuXi AppTec group company, and Prima Biomed have signed a non-binding MOU to form a strategic biologics development and manufacturing partnership.
Drug Research > Drug Discovery & Development > News
Allergan acquires Chase Pharmaceuticals
Allergan has acquired Chase Pharmaceuticals, a clinical-stage biopharmaceutical firm engaged in the development of improved treatments for neurodegenerative disorders including Alzheimer's disease (AD).
Drug Research > Drug Discovery & Development > News
Chemoswed Receives CEP Approval for Benserazide HCl
Chemoswed now officially holds a CEP for benserazide hydrochloride, the latest addition to it’s commercial range of products
Drug Research > Drug Discovery & Development > Press Releases
Chemoswed Acquired by Magle AB
Chemoswed is now a part of the Magle Chemoswed group
Drug Research > Drug Discovery & Development > Press Releases
Chemoswed: Commercial Scale Manufacture of Benserazide Hydrochloride in Main Plant
Chemoswed announces that commercial scale manufacture of benserazide hydrochloride has now been established in the main plant.
Drug Research > Drug Discovery & Development > Press Releases
Chemoswed Reports Successful USFDA Audit
Chemoswed is regularly inspected and certified by the Swedish Medical Products Agency. Additionally, late last year, the facilities were audited by the US Food and Drug Administration during a week-long onsite inspection
Drug Research > Drug Discovery & Development > Press Releases
Chemoswed Renewed GMP Certificate
Following inspections which took place late 2014, Chemoswed has received an updated certificate of GMP compliance.
Drug Research > Drug Discovery & Development > Press Releases
View all Drug Discovery & Development news or find news targeted to your interests